REVVITY, INC Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
REVVITY, INC (RVTY) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $82.16 per share for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2026-02-24
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2021-04-04 was $53.98, a 2.45% increase year-over-year.
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2020-04-05 was $52.69, a 14.02% increase year-over-year.
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2019-03-31 was $46.21, a 6.97% increase year-over-year.
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for the quarter ending 2018-04-01 was $43.20, a 30.55% increase year-over-year.
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2025 was $82.16, a 24.92% increase from fiscal 2024.
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2024 was $65.77, a 13.60% decline from fiscal 2023.
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $76.12, a 5.12% increase from fiscal 2023.
- REVVITY, INC share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2023 was $72.41, a 2.80% increase from fiscal 2022.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-12-28 | $82.16 10-K · filed 2026-02-24 | |||
| 2024-12-29 | $65.77 10-K · filed 2025-02-25 | |||
| 2023-12-31 | $76.12 10-K · filed 2024-02-27 | |||
| 2023-01-01 | $72.41 10-K · filed 2023-03-01 | |||
| 2022-01-02 | $70.44 10-K · filed 2022-03-03 | |||
| 2021-10-03 | $53.98 10-Q · filed 2021-11-09 | |||
| 2021-07-04 | $53.98 10-Q · filed 2021-08-10 | |||
| 2021-04-04 | $53.98 10-Q · filed 2021-05-11 | |||
| 2021-01-03 | $49.31 10-K · filed 2021-03-02 | |||
| 2020-10-04 | $48.67 10-Q · filed 2020-11-10 | |||
| 2020-07-05 | $51.35 10-Q · filed 2020-08-11 | |||
| 2020-04-05 | $52.69 10-Q · filed 2020-05-12 | |||
| 2019-12-29 | $47.60 10-K · filed 2020-02-25 | |||
| 2019-09-29 | $47.30 10-Q · filed 2019-11-05 | |||
| 2019-06-30 | $46.92 10-Q · filed 2019-08-06 | |||
| 2019-03-31 | $46.21 10-Q · filed 2019-05-07 | |||
| 2018-12-30 | $35.02 10-K · filed 2019-02-26 | |||
| 2018-09-30 | $35.19 10-Q · filed 2018-11-06 | |||
| 2018-07-01 | $42.98 10-Q · filed 2018-08-07 | |||
| 2018-04-01 | $43.20 10-Q · filed 2018-05-08 | |||
| 2017-12-31 | $31.16 10-K · filed 2018-02-27 | |||
| 2017-10-01 | $30.88 10-Q · filed 2017-11-07 | |||
| 2017-07-02 | $30.64 10-Q · filed 2017-08-08 | |||
| 2017-04-02 | $33.09 10-Q · filed 2017-05-09 | |||
| 2017-01-01 | $25.04 10-K · filed 2017-02-28 | |||
| 2016-10-02 | $23.58 10-Q · filed 2016-11-08 | |||
| 2016-07-03 | $23.04 10-Q · filed 2016-08-09 | |||
| 2016-04-03 | $20.37 10-Q · filed 2016-05-10 | |||
| 2016-01-03 | $17.56 10-K · filed 2016-03-01 | |||
| 2015-10-04 | $17.42 10-Q · filed 2015-11-10 | |||
| 2015-06-28 | $17.39 10-Q · filed 2015-08-04 | |||
| 2015-03-29 | $15.43 10-Q · filed 2015-05-05 | |||
| 2014-12-28 | $23.89 10-K · filed 2016-03-01 | |||
| 2014-09-28 | $23.55 10-Q · filed 2014-11-04 | |||
| 2014-06-29 | $23.89 10-Q · filed 2014-08-05 | |||
| 2014-03-30 | $23.30 10-Q · filed 2014-05-06 | |||
| 2013-12-29 | $21.45 10-K · filed 2016-03-01 | |||
| 2013-09-29 | $21.20 10-Q · filed 2013-11-05 | |||
| 2013-06-30 | $21.68 10-Q · filed 2013-08-06 | |||
| 2013-03-31 | $21.84 10-Q · filed 2013-05-06 | |||
| 2012-12-30 | $20.16 10-K · filed 2015-02-24 | |||
| 2012-01-01 | $20.86 10-K · filed 2014-02-25 | |||
| 2011-01-02 | $18.82 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |